(Q33456084)

26 July 2017

Tolerability of curcumin in pediatric inflammatory bowel disease: a forced-dose titration study (English)

1 reference

inflammatory bowel diseases

26 July 2017

0 references

curcumin

0 references

author name string

David L Suskind

1

1 reference

26 July 2017

Ghassan Wahbeh

2

1 reference

26 July 2017

Tyler Burpee

3

1 reference

26 July 2017

Morty Cohen

4

1 reference

26 July 2017

Dennis Christie

5

1 reference

26 July 2017

Wendy Weber

6

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 March 2013

1 reference

Journal of Pediatric Gastroenterology and Nutrition

26 July 2017

1 reference

26 July 2017

56

1 reference

26 July 2017

3

1 reference

26 July 2017

277-279

1 reference

Use of complementary medicine in pediatric patients with inflammatory bowel disease: results from a multicenter survey

26 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701433

Curcumin therapy in inflammatory bowel disease: a pilot study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701433

Use of complementary and alternative medicines by children and adolescents with inflammatory bowel disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701433

Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701433

Ferula asa-foetida and Curcuma longa in traditional medical treatment and diet in Nepal

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701433

Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701433

Inhibition of tumor necrosis factor by curcumin, a phytochemical

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701433

Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701433

Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701433

Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701433

Curcumin attenuates DNB-induced murine colitis.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701433

Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3701433

Evaluation of the Pediatric Crohn Disease Activity Index: A Prospective Multicenter Experience

31 October 2018

1 reference

12 December 2020

Preliminary study on antirheumatic activity of curcumin (diferuloyl methane)

1 reference

12 December 2020

Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling

1 reference

12 December 2020

Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation

1 reference

12 December 2020

Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa

1 reference

12 December 2020

Curcumin inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells

1 reference

12 December 2020

Pride and prejudice: inflammatory bowel disease models and drug development

1 reference

12 December 2020

10.1097/MPG.0B013E318276977D

Identifiers

DOI

1 reference

26 July 2017

1 reference

26 July 2017

1 reference